NZ238989A - Activation of proteins chemically and production of fusion proteins biologically - Google Patents

Activation of proteins chemically and production of fusion proteins biologically

Info

Publication number
NZ238989A
NZ238989A NZ238989A NZ23898991A NZ238989A NZ 238989 A NZ238989 A NZ 238989A NZ 238989 A NZ238989 A NZ 238989A NZ 23898991 A NZ23898991 A NZ 23898991A NZ 238989 A NZ238989 A NZ 238989A
Authority
NZ
New Zealand
Prior art keywords
protein
lys
amino acid
arg
terminal
Prior art date
Application number
NZ238989A
Other languages
English (en)
Inventor
Jutta Heim
Peter Seeboth
Kenji Takabayashi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ238989A publication Critical patent/NZ238989A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
NZ238989A 1990-07-18 1991-07-16 Activation of proteins chemically and production of fusion proteins biologically NZ238989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015825A GB9015825D0 (en) 1990-07-18 1990-07-18 In vitro processing of fusion proteins

Publications (1)

Publication Number Publication Date
NZ238989A true NZ238989A (en) 1992-09-25

Family

ID=10679295

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ238989A NZ238989A (en) 1990-07-18 1991-07-16 Activation of proteins chemically and production of fusion proteins biologically

Country Status (19)

Country Link
EP (1) EP0467839B1 (enExample)
JP (1) JP3140488B2 (enExample)
AT (1) ATE141645T1 (enExample)
AU (1) AU651830B2 (enExample)
CA (1) CA2047119C (enExample)
DE (1) DE69121489T2 (enExample)
DK (1) DK0467839T3 (enExample)
ES (1) ES2091897T3 (enExample)
FI (1) FI106720B (enExample)
GB (1) GB9015825D0 (enExample)
GR (1) GR3020840T3 (enExample)
HU (1) HU216104B (enExample)
IE (1) IE73209B1 (enExample)
NO (1) NO303132B1 (enExample)
NZ (1) NZ238989A (enExample)
PT (1) PT98332B (enExample)
SG (1) SG49863A1 (enExample)
TW (1) TW209247B (enExample)
ZA (1) ZA915579B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525491A (en) * 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
CA2213512A1 (en) * 1995-12-22 1997-07-03 Toray Industries, Inc. Method for producing bioactive fusion protein
US6800726B1 (en) 1996-11-01 2004-10-05 Pioneer Hi-Bred International, Inc. Proteins with increased levels of essential amino acids
US6265204B1 (en) 1997-01-17 2001-07-24 Genencor International, Inc. DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
GB9716790D0 (en) 1997-08-07 1997-10-15 Creative Peptides Sweden Ab Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof
WO2014138371A1 (en) 2013-03-06 2014-09-12 Glaxosmithkline Llc Host cells and methods of use
CN118515782B (zh) * 2024-06-03 2025-03-18 浙江毓昌生物技术有限公司 一种融合蛋白及基于该融合蛋白制备重组人生长激素的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation
US5010182A (en) * 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid

Also Published As

Publication number Publication date
JPH04229188A (ja) 1992-08-18
DE69121489T2 (de) 1997-02-27
IE912501A1 (en) 1992-01-29
PT98332B (pt) 1999-01-29
GR3020840T3 (en) 1996-11-30
AU651830B2 (en) 1994-08-04
DE69121489D1 (de) 1996-09-26
HU912398D0 (en) 1991-12-30
ZA915579B (en) 1992-03-25
CA2047119C (en) 2002-10-08
TW209247B (enExample) 1993-07-11
NO912803D0 (no) 1991-07-17
FI913405A7 (fi) 1992-01-19
AU8046391A (en) 1992-01-23
NO912803L (no) 1992-01-20
EP0467839A1 (en) 1992-01-22
CA2047119A1 (en) 1992-01-19
SG49863A1 (en) 2002-03-19
ATE141645T1 (de) 1996-09-15
FI106720B (fi) 2001-03-30
EP0467839B1 (en) 1996-08-21
ES2091897T3 (es) 1996-11-16
FI913405A0 (fi) 1991-07-15
HU216104B (hu) 1999-04-28
NO303132B1 (no) 1998-06-02
HUT58369A (en) 1992-02-28
GB9015825D0 (en) 1990-09-05
DK0467839T3 (da) 1996-09-16
JP3140488B2 (ja) 2001-03-05
IE73209B1 (en) 1997-05-07
PT98332A (pt) 1992-05-29

Similar Documents

Publication Publication Date Title
US6500645B1 (en) N-terminally extended proteins expressed in yeast
JP2528849B2 (ja) 置換されたプロモ−タ−を使用する宿主による異種起原蛋白質の増強された分泌
RU2143495C1 (ru) Способ получения гетерологичного белка
AU660161B2 (en) A method of constructing synthetic leader sequences
WO1995035384A1 (en) N-terminally extended proteins expressed in yeast
NO175266B (no) Fremgangsmåte for fremstilling av et humant t-PA protein som mangler en eller flere av de N-bundne karbohydratrestene, DNA, hybridvektor samt transformert eukaryot vertscelle som er i stand til å uttrykke et humant t-PA protein
AU667852B2 (en) Novel DNA molecules and hosts
US6171823B1 (en) Process for producing extracellular proteins in bacteria
CA2093950C (en) Subtilisin-like protease from aspergillus niger
JP4187796B2 (ja) 酵母で発現されたｎ末端伸長タンパク質
EP0467839B1 (en) In vitro processing of fusion proteins
EP0868523B1 (en) Vector for expression of n-terminally extended proteins in yeast cell
JP2769541B2 (ja) 平衡型構成誘導性転写系
RU2167939C2 (ru) Способ продуцирования полипептида в дрожжах

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired